Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.0%

3 terminated out of 50 trials

Success Rate

89.7%

+3.1% vs benchmark

Late-Stage Pipeline

16%

8 trials in Phase 3/4

Results Transparency

27%

7 of 26 completed with results

Key Signals

7 with results90% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (18)
P 1 (7)
P 2 (5)
P 3 (5)
P 4 (3)

Trial Status

Completed26
Unknown6
Recruiting5
Not Yet Recruiting3
Active Not Recruiting3
Terminated3

Trial Success Rate

89.7%

Benchmark: 86.6%

Based on 26 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT05612347Not ApplicableRecruiting

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

NCT05209568Not ApplicableEnrolling By Invitation

Immune Responses to Gluten

NCT06271538Phase 4Completed

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

NCT07076641Phase 3Not Yet RecruitingPrimary

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

NCT05401058Not ApplicableTerminatedPrimary

Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery

NCT05489237Phase 1Active Not Recruiting

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

NCT04084249Not ApplicableActive Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT05066139Not ApplicableRecruitingPrimary

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

NCT05253287Phase 2Completed

Growth Hormone in Decompensated Liver Cirrhosis

NCT07114406Phase 3Not Yet Recruiting

A Study to Evaluate Safety and Efficacy of PBK_M2502

NCT05405842Not ApplicableWithdrawn

Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis

NCT03037385Phase 1Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03646292Phase 4Completed

Antidiabetic Drugs for Steatotic Liver Disease

NCT04475952Recruiting

Early Diagnosis of Upper Digestive Tract Disease

NCT03535727Phase 1Completed

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

NCT05829720Not ApplicableCompletedPrimary

Investigate Effects of A2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in Healthy, Full-term Infants

NCT05251467Completed

A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF

NCT05253859Completed

CFTR Modulators and Gastrointestinal Complications

NCT05160168Phase 1Terminated

A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT06351202Not ApplicableRecruiting

Impact Assessment of Abdominal Massage on Feeding Tolerance of Preterms

Scroll to load more

Research Network

Activity Timeline